Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Recent Articles
- American Rebel Light Beer Sponsors Exciting Concert Series
- SAIHEAT’s Groundbreaking Patent for Small Modular Reactor Control
- Ernexa Therapeutics Launches Texas Subsidiary to Accelerate ERNA-101
- Ethical Web AI Launches AI Vault on AWS Marketplace for Enterprises
- FDCTech's Remarkable Q1 2025 Growth and Future Prospects
- LPL Financial Unveils Innovative Alternatives Education Hub
- iPower's New Initiative: Boosting Domestic Manufacturing Success
- CleanCore Solutions Surges with 77.7% Revenue Growth This Quarter
- Blüm Holdings Inc. Shows Significant Growth in Q1 2025 Results
- Impressive Growth in NETSOL Technologies' Q3 Performance
- Brag House Firmly Investigates Potential Illegal Short Selling
- Robex's Kiniero Gold Project Nears Completion Ahead of Schedule
- Join Inuvo, Inc. at the Upcoming Innovation Expo Event
- Surrozen's Latest Patent Marks Milestone in Wnt Pathway Therapy
- Star Equity Holdings, Inc. Q1 2025 Financial Analysis
- ArcelorMittal Updates on Designated Person Notifications
- RIAS A/S Shares Insights from Recent Half-Year Performance
- Landsbankinn's Successful Covered Bond Exchange Results Explained
- Innovative Partnership to Revolutionize Programmatic Audio Ads
- Empowering Latinas: Highlights from the 22nd Annual Symposium
- Tres Picosos Expands Presence with Authentic Burritos at Safeway
- Clint Ridenour of Teamwork Commerce to Share Insights at Event
- Innovative sNPWT Solution Brings Significant Savings to Healthcare
- Explore Unique Global Journeys with Four Seasons Private Jet
- Morae Expands Legal Tech Solutions with Gimmal Acquisition
- IQSTEL Inc. Marks New Journey by Trading on NASDAQ Today
- Explore ComfoRest's New Website for Premium Beds Online
- La Madeleine Revives Dining with Affordable 'Le Pick 3' Menu
- Boosting Online Presence: FlexiHeat UK Partners with Digitaleer
- Gentoo Media Announces Significant Share Acquisition by Insider
- Algorhythm Holdings Set to Reveal Q1 2025 Financials Soon
- FAMAR Group Expands with Strategic Acquisition in Europe
- Atossa Therapeutics Shares Significant Progress in Tumor Treatment
- Daxor's Innovative Blood Volume Analysis Transforming Heart Failure Care
- Transforming Financial Services with AI: Introducing TIFIN AXIS
- Armlogi Holding Corp. Set for Third Quarter Results Conference
- Discover the New 18 oz. Original Flavor from Mary's Gone Crackers
- OxyCon 2025: Embracing the Future of Web Scraping Together
- Burford Capital Transition to MSCI USA Index: Implications Ahead
- Aqua-Tots Swim School Expands with New Location in NJ
- Cellarity Names Ted Myles as New CEO, Driving Innovation Forward
- INmune Bio Inc. to Present at Key Healthcare Conference
- Understanding the Shopping Trends Among Gen Z and Millennials
- FAMAR Group Expands Operations with New Acquisition in Germany
- Exciting Prizes for Fans in Jason Aldean's Full Throttle Tour
- Urban Outfitters Unveils Innovative Retail Experience with Nike
- Explore Decentralized AI Insights with the Alpha Liquid Podcast
- Antalpha's IPO: A New Frontier in Crypto Finance Funding
- Innovative Growth Strategies by Safe & Green Holdings Corp.
- Enhancing Urban Green Spaces: The Evolution of Barrios Unidos Park